Publication | Closed Access

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

Hidden BiasRheumatologyRheumatoid DisorderAnti-inflammatoryDouble-blind TrialsRheumatic DiseasesPharmacologyClinical TrialsInflammatory Rheumatic DiseasePharmacotherapyMedicineRheumatoid Arthritis